Header image

Concurrent Session 1A: Opioid Prescribing: Clinical Realities

Tracks
.
Monday, November 9, 2026
1:30 PM - 3:00 PM
Pleiades

Speaker

Agenda Item Image
Mr Paul Dessauer
Chief Executive Officer
Peer Based Harm Reduction WA

Introduction & Welcome

1:30 PM - 1:35 PM

Paul is CEO of Peer Based Harm Reduction WA (PBHR WA), Western Australia’s only peer-based consumer-led AOD service, which provides free health and harm reduction services for people who use drugs. Paul has worked at PBHR WA for >25 years, delivering and coordinating outreach services, overdose prevention, take-home-naloxone, and peer-education projects, while providing consultancy to researchers and policy makers and workforce development to other front-line agencies. Paul has previously worked as a Drug & Alcohol Officer for the State-wide Specialist Aboriginal Mental Health Service; an educator & consultant for the Transnational Institute (in China and Myanmar); and a trainer for the Burnet Institute. Paul is committed to addressing stigmatisation directed at, improving the health equity of, and promoting the fundamental human rights of, people who use drugs. In all his work Paul strives to bring the voices and living experience of people who use drugs to research, policy, and practice.
Ms Lucy Tran
PhD Candidate, Research Officer
NDARC

Co-occurring mental disorders and retention in buprenorphine and methadone treatment for opioid use disorder: A retrospective data linkage cohort study

1:35 PM - 1:45 PM

Abstract PDF

Lucy Tran (BSci, BPsySc(Hons), MClinPsy) has worked across multiple projects examining the risks and harms associated with different illicit drug use and dependence. Lucy is a Clinical Psychologist and PhD candidate, with her PhD exploring the association of mental disorders on treatment outcomes among people dependent on methamphetamine or opioids.
Mr. Nicholas Kent
Policy & Advocacy Manager
Harm Reduction Victoria

Facilitating a lived & living experience review of opioid dependence treatment in Victoria

1:45 PM - 1:55 PM

Abstract PDF

Nick Kent is an advocate working in harm reduction and drug policy reform, with a background in education and policy studies. Nick works on reform projects at state, national and international leves, and works with diverse communities of people who use drugs in community peer education, research and advocacy.
Agenda Item Image
Professor Paul Dietze
Co_director, Disease Elimination Program
Burnet Institute

The relationship between opioid agonist therapy and reduced injecting frequency amongst people who inject drugs: Evidence from a prospective cohort study

1:55 PM - 2:05 PM

Abstract PDF

Professor Dietze is one of Australia's leading alcohol and other drug years' with over 30 years' experience in the field.
Agenda Item Image
Professor Paul Dietze
Co_director, Disease Elimination Program
Burnet Institute

Supervised Injecting Room Use and Mental Health Contacts: Findings from the SuperMIX Cohort

2:05 PM - 2:15 PM

Abstract PDF

Ash is a Research Fellow at the Burnet Institute in Melbourne with expertise in applied public health research. She leads the Supervised Injecting Room Cohort Study.
Agenda Item Image
Professor Michael Doyle
Head Of First Nations Health Research
Edith Collins Centre, The University Of Sydney

Zones of abandonment: Understanding LAIB discontinuation among Aboriginal people after release from custody

2:15 PM - 2:25 PM

Abstract PDF

Professor Michael Doyle is a Bardi Man and a research-focused academic at the University of Sydney. He has worked in Aboriginal health for over 20 years, commencing his career as an Aboriginal Health Worker at the Broome Regional Aboriginal Medical Service. Michael moved into Aboriginal health research in 2008 and utilises a mixed-methods approach in his work. Presently, Michael is the Head of the First Nations health team at the Edith Collins Centre for translational research in alcohol, drugs, and toxicology. His research aims to improve health service delivery for Aboriginal and Torres Strait Islander people who use alcohol and/or other drugs. Michael's research also has a focus on improving health service delivery for those in the criminal justice system. Michael is an active member of the Aboriginal community and has served on Aboriginal community-controlled organisation boards. He served as co-chair of the Aboriginal Health and Medical Research Council of NSW's Human Research Ethics Committee 2021 to 2026 (May).
APSAD 2026

Discussion

2:25 PM - 2:45 PM

APSAD 2026

Session Q&A

2:45 PM - 3:00 PM


Chair

Agenda Item Image
Paul Dessauer
Chief Executive Officer
Peer Based Harm Reduction WA

loading